| Product NDC: | 58406-425 |
| Proprietary Name: | ENBREL |
| Non Proprietary Name: | etanercept |
| Active Ingredient(s): | & nbsp; etanercept |
| Administration Route(s): | |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 58406-425 |
| Labeler Name: | Immunex Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA103795 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20030102 |
| Package NDC: | 58406-425-34 |
| Package Description: | 4 KIT in 1 CARTON (58406-425-34) > 1 KIT in 1 KIT (58406-425-41) * 1 mL in 1 VIAL * 1 mL in 1 SYRINGE (58406-910-01) |
| NDC Code | 58406-425-34 |
| Proprietary Name | ENBREL |
| Package Description | 4 KIT in 1 CARTON (58406-425-34) > 1 KIT in 1 KIT (58406-425-41) * 1 mL in 1 VIAL * 1 mL in 1 SYRINGE (58406-910-01) |
| Product NDC | 58406-425 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | etanercept |
| Dosage Form Name | KIT |
| Route Name | |
| Start Marketing Date | 20030102 |
| Marketing Category Name | BLA |
| Labeler Name | Immunex Corporation |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |